STAT3 and osteosarcoma: In addition, STAT3 activation was reported to promote mesenchymal stem cells-induced osteosarcoma cell survival and drug resistance while blocking STAT3 signaling revert resistance to chemotherapy in osteosarcoma Saos-2 cells to drug treatment [35].